Literature DB >> 21194356

Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries.

Veerle Matheeussen1, Lesley Baerts, Guido De Meyer, Gilles De Keulenaer, Pieter Van der Veken, Koen Augustyns, Véronique Dubois, Simon Scharpé, Ingrid De Meester.   

Abstract

Dipeptidyl peptidase IV (DPPIV)/CD26 is by far the most extensively studied member of the prolyl oligopeptidase family of serine proteases. The discovery of the related enzymes DPP8 and DPP9 necessitates a (re-)evaluation of the DPPIV-like enzymatic activity in cells and organs. In this study, we aimed (1) to investigate the expression of the individual dipeptidyl peptidases in different types of endothelial cells (ECs) and (2) to reconsider published data in relation to our findings. Examination of DPP expression in rat primary ECs of aortic, endocardial and cardiac microvascular origin revealed the presence of DPPIV-like activity in all cell lysates. More than half of this activity could be attributed to DPP8/9. Western blot analysis revealed an abundance of the DPP8 protein as compared to DPP9. The expression of DPPIV and DPP8 was significantly higher in the cardiac microvascular endothelium than in the other ECs, suggesting a more pronounced role of these DPPs in the microvasculature. In situ, DPP activity in ventricular microvasculature was completely inhibited by sitagliptin, indicating that DPPIV is the predominant DPPIV-like enzyme in this organ. By contrast, immunohistochemical studies indicated DPP9 as the predominant DPP in human carotid artery ECs. In conclusion, our results support a highly regulated expression of individual DPPs in ECs, with a spatial heterogeneity in the cardiovascular tree.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21194356     DOI: 10.1515/BC.2011.002

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  26 in total

1.  Impact of DPP-4 inhibition on acute and chronic endothelial function in humans with type 2 diabetes on background metformin therapy.

Authors:  Michael E Widlansky; Venkata K Puppala; Tisha M Suboc; Mobin Malik; Amberly Branum; Kara Signorelli; Jingli Wang; Rong Ying; Michael J Tanner; Sudhi Tyagi
Journal:  Vasc Med       Date:  2017-02-01       Impact factor: 3.239

2.  Sex differences influencing micro- and macrovascular endothelial phenotype in vitro.

Authors:  Virginia H Huxley; Scott S Kemp; Christine Schramm; Steve Sieveking; Susan Bingaman; Yang Yu; Isabella Zaniletti; Kevin Stockard; Jianjie Wang
Journal:  J Physiol       Date:  2018-07-15       Impact factor: 5.182

Review 3.  GLP-1, the gut-brain, and brain-periphery axes.

Authors:  Cendrine Cabou; Rémy Burcelin
Journal:  Rev Diabet Stud       Date:  2011-11-10

4.  CD26 Identifies a Subpopulation of Fibroblasts that Produce the Majority of Collagen during Wound Healing in Human Skin.

Authors:  Christal A Worthen; Yilei Cui; Jeffrey S Orringer; Timothy M Johnson; John J Voorhees; Gary J Fisher
Journal:  J Invest Dermatol       Date:  2020-05-11       Impact factor: 8.551

Review 5.  Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide.

Authors:  Emanuel Monteiro Candeias; Inês Carolina Sebastião; Susana Maria Cardoso; Sónia Catarina Correia; Cristina Isabel Carvalho; Ana Isabel Plácido; Maria Sancha Santos; Catarina Resende Oliveira; Paula Isabel Moreira; Ana Isabel Duarte
Journal:  World J Diabetes       Date:  2015-06-25

Review 6.  The expression of proline-specific enzymes in the human lung.

Authors:  Gwendolyn Vliegen; Tom K Raju; Dirk Adriaensen; Anne-Marie Lambeir; Ingrid De Meester
Journal:  Ann Transl Med       Date:  2017-03

7.  PTH/SDF-1α cotherapy promotes proliferation, migration and osteogenic differentiation of human periodontal ligament stem cells.

Authors:  Lingqian Du; Ruijuan Feng; Shaohua Ge
Journal:  Cell Prolif       Date:  2016-08-14       Impact factor: 6.831

8.  Cardiovascular safety of dipeptidyl peptidase-4 inhibitors: recent evidence on heart failure.

Authors:  Saumya Reddy Kankanala; Rafay Syed; Quan Gong; Boxu Ren; Xiaoquan Rao; Jixin Zhong
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

9.  Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats.

Authors:  Kosuke Kaji; Hitoshi Yoshiji; Yasuhide Ikenaka; Ryuichi Noguchi; Yosuke Aihara; Akitoshi Douhara; Kei Moriya; Hideto Kawaratani; Yusaku Shirai; Junichi Yoshii; Koji Yanase; Mitsuteru Kitade; Tadashi Namisaki; Hiroshi Fukui
Journal:  J Gastroenterol       Date:  2013-03-12       Impact factor: 7.527

10.  Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer.

Authors:  Arpi Nazarian; Kevin Lawlor; San San Yi; John Philip; Mousumi Ghosh; Mariana Yaneva; Josep Villanueva; Alan Saghatelian; Melissa Assel; Andrew J Vickers; James A Eastham; Howard I Scher; Brett S Carver; Hans Lilja; Paul Tempst
Journal:  Mol Cell Proteomics       Date:  2014-07-23       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.